Krystal Biotech, Inc. (NASDAQ: KRYS) today announced the pricing of its initial public offering. The offering was upsized to 3,960,000 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE